Find

Department of Clinical Medicine

Medical/Steno Aarhus Research Laboratory

Publications

Search for a publication

List of publications

Sort by: Date | Author | Title

Glintborg, D., Rungby, J., Eskildsen, P., Hermann, A. P., Stecher, C. W. & Andersen, M. (2010). Endokrinologisk udredning, behandling og opfølgning af polycystisk ovariesyndrom. Ugeskrift for Læger, 172(3), 196-9.

Gormsen, L. C., Høst, C., Hjerrild, B. E., Gravholt, C. H. & Nielsen, S. (2010). Acute estrogen exposure does not affect basal VLDL-TG production or oxidation in post-menopausal women. European Journal of Endocrinology, 163(3), 421-426. https://doi.org/10.1530/EJE-10-0551

Gude, A. J. & Christiansen, J. S. (2010). Comment and reply on: Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease. Expert Opinion on Pharmacotherapy, 11(9), 1603-4. https://doi.org/10.1517/14656561003768397

Gustafsson, S., Lind, L., Zethelius, B., Venge, P., Flyvbjerg, A., Söderberg, S. & Ingelsson, E. (2010). Adiponectin, cardiac geometry and function in elderly: results from two community-based cohort studies. European Journal of Endocrinology, 162(3), 543-550. https://doi.org/10.1530/EJE-09-1006

Hagen, C. P., Aksglaede, L., Sørensen, K., Main, K. M., Boas, M., Cleemann, L., Holm, K., Gravholt, C. H., Andersson, A.-M., Pedersen, A. T., Petersen, J. H., Linneberg, A., Kjaergaard, S. & Juul, A. (2010). Serum Levels of Anti-Mullerian Hormone as a Marker of Ovarian Function in 926 Healthy Females from Birth to Adulthood and in 172 Turner Syndrome Patients. Journal of Clinical Endocrinology and Metabolism, 95(11), 5003-7. https://doi.org/10.1210/jc.2010-0930

Halbirk, M., Nørrelund, H., Møller, N., Holst, J. J., Schmitz, O., Nielsen, B. R. R., Nielsen-Kudsk, J. E., Nielsen, S. S., Nielsen, T. T., Eiskjær, H., Bøtker, H. E. & Wiggers, H. (2010). Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure. American Journal of Physiology: Heart and Circulatory Physiology, 298(3), 1096-1102.

Halbirk, M., Nørrelund, H., Møller, N., Holst, J. J., Schmitz, O., Nielsen, R., Nielsen-Kudsk, J. E., Nielsen, S. S., Toftegård, T., Eiskjær, H., Bøtker, H. E. & Wiggers, H. (2010). Cardiovascular and Metabolic Effects of 48-Hour Glucagon-like Peptide 1 Infusion in Compensated Chronic Heart Failure Patients. American Journal of Physiology: Heart and Circulatory Physiology, 298(3), H1096-102. https://doi.org/10.1152/ajpheart.00930.2009

Halbirk, M., Nørrelund, H., Møller, N., Schmitz, O., Bøtker, H. E. & Wiggers, H. (2010). Short-term changes in circulating insulin and free fatty acids affect Nt-pro-BNP levels in heart failure patients. International Journal of Cardiology, 144(1), 140-2. https://doi.org/10.1016/j.ijcard.2008.12.152

Halbirk, M., Nørrelund, H., Møller, N., Schmitz, O., Gøtzsche, L., Nielsen, B. R. R., Nielsen-Kudsk, J. E., Nielsen, S. S., Nielsen, T. T., Eiskjær, H., Bøtker, H. E. & Wiggers, H. (2010). Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function. American Journal of Physiology: Heart and Circulatory Physiology, 299(4), 1220-25.

Halbirk, M., Nørrelund, H., Møller, N., Schmitz, O., Gøtzsche, L., Nielsen, R., Nielsen-Kudsk, J. E., Nielsen, S. S., Nielsen, T. T., Eiskjær, H., Bøtker, H. E. & Wiggers, H. (2010). Suppression of Circulating Free Fatty Acids with Acipimox in Chronic Heart Failure Patients Changes Whole Body Metabolism but Does not Affect Cardiac Function. American Journal of Physiology: Heart and Circulatory Physiology, 299(4), H1220-5. https://doi.org/10.1152/ajpheart.00475.2010

Displaying results 3051 to 3060 out of 4099

306

Revised 11.09.2025

-

Department of Clinical Medicine